A new study raises questions about how financial stress fits into cardiovascular health. Dr. Leana Wen explains what people ...

The PCE was developed by the American College of Cardiology and American Heart Association and uses factors such as age, sex, ...

The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...

BioAge’s NLRP3 inhibitor has shown potential to reduce high-sensitivity C-reactive protein (hsCRP), a key marker of ...

Cardiovascular risk factors, including higher body mass index (BMI) and waist circumference, in childhood and adolescence are ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Elizabeth Cooney became STAT’s cardiovascular reporter in April with one fundamental question in mind: Why do we have so much cardiovascular and metabolic disease, and how can we do better? Elizabeth ...

Young adults may face higher risks of cardiovascular disease due to factors like obesity or inactivity. Here, three younger ...

The prevalence of anti-citrullinated protein antibodies is low in patients with coronary artery disease without RA; in those with RA, C-reactive protein levels may explain the antibody-mortality link.

UM cardiovascular experts lead pioneering stem cell research, developed a nationally recognized AHA certified model for ...

Humann offers a range of supplements targeting cardiovascular health, blood pressure, cholesterol, metabolism, joint health and cognitive health.